Amit B. Shah - Net Worth and Insider Trading

Amit B. Shah Net Worth

The estimated net worth of Amit B. Shah is at least $1,740 dollars as of 2024-11-08. Amit B. Shah is the CHIEF FINANCIAL OFFICER of Oncotelic Therapeutics Inc and owns about 60,000 shares of Oncotelic Therapeutics Inc (OTLC) stock worth over $1,740. Details can be seen in Amit B. Shah's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amit B. Shah has not made any transactions after 2020-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Amit B. Shah

To

Amit B. Shah Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amit B. Shah owns 2 companies in total, including Adhera Therapeutics Inc (ATRX) , and Oncotelic Therapeutics Inc (OTLC) .

Click here to see the complete history of Amit B. Shah’s form 4 insider trades.

Insider Ownership Summary of Amit B. Shah

Ticker Comapny Transaction Date Type of Owner
ATRX Adhera Therapeutics Inc 2017-10-02 Chief Financial Officer
OTLC Oncotelic Therapeutics Inc 2020-11-24 CHIEF FINANCIAL OFFICER

Amit B. Shah Latest Holdings Summary

Amit B. Shah currently owns a total of 1 stock. Amit B. Shah owns 60,000 shares of Oncotelic Therapeutics Inc (OTLC) as of November 24, 2020, with a value of $1,740.

Latest Holdings of Amit B. Shah

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OTLC Oncotelic Therapeutics Inc 2020-11-24 60,000 0.03 1,740

Holding Weightings of Amit B. Shah


Amit B. Shah Form 4 Trading Tracker

According to the SEC Form 4 filings, Amit B. Shah has made a total of 1 transactions in Oncotelic Therapeutics Inc (OTLC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncotelic Therapeutics Inc is the acquisition of 60,000 shares on November 24, 2020, which cost Amit B. Shah around $11,400.

Insider Trading History of Amit B. Shah

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amit B. Shah Trading Performance

GuruFocus tracks the stock performance after each of Amit B. Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amit B. Shah is 48.27%. GuruFocus also compares Amit B. Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amit B. Shah within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Amit B. Shah's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Amit B. Shah

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.39 LIMIT LIMIT LIMIT LIMIT LIMIT

Amit B. Shah Ownership Network

Ownership Network List of Amit B. Shah

No Data

Ownership Network Relation of Amit B. Shah

Insider Network Chart

Amit B. Shah Owned Company Details

What does Adhera Therapeutics Inc do?

Who are the key executives at Adhera Therapeutics Inc?

Amit B. Shah is the Chief Financial Officer of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .

Adhera Therapeutics Inc (ATRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adhera Therapeutics Inc Insider Transactions

No Available Data

Amit B. Shah Mailing Address

Above is the net worth, insider trading, and ownership report for Amit B. Shah. You might contact Amit B. Shah via mailing address: 10 Aguila, Aliso Viejo Ca 92656.